Henry Schein (NASDAQ:HSIC) Updates FY24 Earnings Guidance

Henry Schein (NASDAQ:HSIC) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $5.00 to $5.16 for the period, compared to the consensus estimate of $5.06. The company issued revenue guidance of +8-10% yr/yr or $13.326 billion to $13.573 billion from +8, compared to the consensus revenue estimate of $13.42 billion.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on HSIC shares. Piper Sandler increased their price objective on shares of Henry Schein from $78.00 to $86.00 and gave the stock an overweight rating in a research report on Monday, February 26th. Leerink Partnrs reissued a market perform rating on shares of Henry Schein in a research report on Monday, February 26th. TheStreet upgraded Henry Schein from a c+ rating to a b- rating in a research note on Monday, February 26th. Evercore ISI raised their target price on Henry Schein from $79.00 to $83.00 and gave the stock an in-line rating in a research note on Wednesday, February 28th. Finally, JPMorgan Chase & Co. increased their price target on Henry Schein from $82.00 to $88.00 and gave the stock an overweight rating in a research report on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of Hold and a consensus price target of $81.73.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC traded up $1.56 during trading on Wednesday, reaching $72.76. The company had a trading volume of 1,875,896 shares, compared to its average volume of 1,108,219. Henry Schein has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. The stock’s fifty day moving average price is $73.08 and its 200 day moving average price is $72.34. The firm has a market capitalization of $9.35 billion, a price-to-earnings ratio of 23.16, a price-to-earnings-growth ratio of 1.68 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. Henry Schein’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.21 EPS. As a group, equities research analysts predict that Henry Schein will post 5.07 EPS for the current year.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares in the company, valued at $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.